Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osteo-Form
- Development stage
- Unknown
- Lead developer
- Lloyd Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Osteo-Form is a veterinary nutritional supplement developed and manufactured by LLOYD, Inc. (Lloyd Pharma). It is formulated as a powder or chewable tablet containing a balanced ratio of calcium and phosphorus, along with vitamins A, D3, and C. The product is primarily indicated for the correction of dietary deficiencies and as an aid in the treatment of metabolic bone diseases, such as rickets or osteomalacia, in dogs, cats, and horses. By providing essential minerals and vitamins, Osteo-Form supports bone mineralization, structural integrity, and collagen matrix synthesis, particularly in pregnant, lactating, or rapidly growing animals.
- Brand names
- Osteo-FormOsteo-Form Powder
02
Targets
RAR (Retinoic acid receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Osteo-Form.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osteo-Form.